| Product Code: ETC12838699 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Sweden saw a steady increase in influenza medications import shipments with a Compound Annual Growth Rate (CAGR) of 4.69% from 2020 to 2024. The top exporting countries to Sweden for these medications were Denmark, Belgium, Germany, Netherlands, and Italy. Despite the growth, the market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low in 2024. The significant growth rate of 17.54% from 2023 to 2024 indicates a rising demand for influenza medications in Sweden, making it an attractive market for exporters.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Influenza Medications Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Sweden Influenza Medications Market - Industry Life Cycle |
3.4 Sweden Influenza Medications Market - Porter's Five Forces |
3.5 Sweden Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Sweden Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Sweden Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Sweden Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Sweden |
4.2.2 Growing awareness about the importance of early treatment for influenza |
4.2.3 Technological advancements in influenza medication development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of influenza medications |
4.3.2 Competition from alternative treatments such as home remedies |
4.3.3 Potential side effects associated with certain influenza medications |
5 Sweden Influenza Medications Market Trends |
6 Sweden Influenza Medications Market, By Types |
6.1 Sweden Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Sweden Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Sweden Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Sweden Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Sweden Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Sweden Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Sweden Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Sweden Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Sweden Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Sweden Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Sweden Influenza Medications Market Import-Export Trade Statistics |
7.1 Sweden Influenza Medications Market Export to Major Countries |
7.2 Sweden Influenza Medications Market Imports from Major Countries |
8 Sweden Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases reported annually in Sweden |
8.2 Adoption rate of new influenza medications in the market |
8.3 Research and development investments in the influenza medication sector |
8.4 Patient adherence rate to prescribed influenza medications |
8.5 Number of healthcare providers recommending specific influenza medications |
9 Sweden Influenza Medications Market - Opportunity Assessment |
9.1 Sweden Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Sweden Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Sweden Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Sweden Influenza Medications Market - Competitive Landscape |
10.1 Sweden Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Sweden Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here